ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 254 out of 1499

$645K Total Retail Price of All Prescriptions

Rank: 200 out of 1499

734 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 734 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,228 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 420 397 1 2
SIMVASTATIN 413 368 2 3
LISINOPRIL 396 347 3 1
ZOLPIDEM TARTRATE 342 148 4 23
OMEPRAZOLE 307 268 5 5
HYDROCODONE-ACETAMINOPHEN 280 196 S3 6 4
AMLODIPINE BESYLATE 268 253 7 6
HYDROCHLOROTHIAZIDE 238 216 8 9
PRAVASTATIN SODIUM 237 228 9 18
METOPROLOL TARTRATE 229 224 10 10
CITALOPRAM HBR 217 124 11 14
HYDROXYZINE HCL 215 0 R 12 173
SERTRALINE HCL 198 115 13 24
POTASSIUM CHLORIDE 173 170 14 11
METFORMIN HCL 167 165 15 8
TRAZODONE HCL 159 20 16 32
FUROSEMIDE 157 139 17 7
WARFARIN SODIUM 143 128 18 12
ALENDRONATE SODIUM 142 140 19 33
ATORVASTATIN CALCIUM 137 128 20 17
FLUOXETINE HCL 136 21 21 43
LOSARTAN POTASSIUM 135 133 22 26
CARVEDILOL 132 117 23 22
TAMSULOSIN HCL 125 104 24 29
BUPROPION HCL SR 122 16 25 151
LOVASTATIN 116 115 26 19
GABAPENTIN 115 76 27 13
TRAMADOL HCL 108 84 28 16
METOPROLOL SUCCINATE 107 102 29 20
PAROXETINE HCL 105 61 30 59
SYNTHROID 93 64 31 68
PANTOPRAZOLE SODIUM 90 76 32 48
RANITIDINE HCL 89 71 33 15
AMITRIPTYLINE HCL 88 49 R 34 49
METFORMIN HCL ER 87 76 35 53
ATENOLOL 86 67 36 21
AMPHETAMINE SALT COMBO 83 0 S2 37 307
CYCLOBENZAPRINE HCL 83 51 R 37 41
QUETIAPINE FUMARATE 78 0 39 72
DIOVAN 74 74 40 58
QUINAPRIL HCL 71 71 41 125
CIPROFLOXACIN HCL 71 63 41 65
VENLAFAXINE HCL ER 69 16 43 96
ENALAPRIL MALEATE 66 62 44 75
TRIAMTERENE-HCTZ 66 52 44 62
AZITHROMYCIN 66 54 44 45
OXYBUTYNIN CHLORIDE 65 65 47 95
MELOXICAM 65 51 47 27
ABILIFY 65 0 47 143
NORTRIPTYLINE HCL 65 24 47 203
CARISOPRODOL 56 0 R 51 71
SEROQUEL XR 56 0 51 196
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 52 51 25
NAPROXEN 55 51 54 63
TRICOR 54 26 55 103
FLUTICASONE PROPIONATE 53 35 56 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.